40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
20 °P sammeln
40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
20 °P sammeln
Als Download kaufen
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
20 °P sammeln
Jetzt verschenken
40,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
20 °P sammeln
  • Format: PDF

This book presents the cellular details and the basic molecular biology approaches for understanding cardiac valvular disease. It provides novel cellular targets for developing future clinical trials and comprehensive clinical discussion of this expanding field.
Molecular Biology of Valvular Heart Disease will guide physicians on the potential medical therapies to treat valvular heart disease while providing a platform for cellular targeting of valvular heart disease. Residents and fellows in cardiology, interventional cardiology, cardiac surgery, and current and future valve biologists…mehr

Produktbeschreibung
This book presents the cellular details and the basic molecular biology approaches for understanding cardiac valvular disease. It provides novel cellular targets for developing future clinical trials and comprehensive clinical discussion of this expanding field.

Molecular Biology of Valvular Heart Disease will guide physicians on the potential medical therapies to treat valvular heart disease while providing a platform for cellular targeting of valvular heart disease. Residents and fellows in cardiology, interventional cardiology, cardiac surgery, and current and future valve biologists alike will find this book to be an invaluable resource for developing further interest and understanding of the cellular basis for cardiac valvular disease treatment.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Nalini M. Rajamannan, MD has been studying the cellular biology of valvular heart disease since 1987. She has trained at the Mayo Clinic, in molecular biology, cardiology and echocardiography to develop an expertise which is translational in the approach towards valvular medicine. Her expertise has developed the initial experimental models towards studying medical therapies for this disease process. She is the chair of NHLBI/NIH working group in calcific aortic valve disease. This white paper was published in Circulation in Oct 2011. She has had NIH funding in this field since 2002 and has published 60 papers, several book chapters and the most recent textbook in Cardiac Valvular Medicine. She also has 3 patents in the field of cardiac valve signaling and pathogenesis of this disease.